Background {#j_jccm-2017-0029_s_001}
==========

*Fusobacterium* is an anaerobic gram-negative bacteria which is often involved in the development of Lemierres syndrome\[[@j_jccm-2017-0029_ref_001]\], although other bacteria, such as other fusobacteria or Streptococcus, can also be related to this syndrome\[[@j_jccm-2017-0029_ref_002]\]. The most common species isolated within this genus are *F. nucleatum* and *F. necrophorum. Fusobacterium* are usually found as part of the normal oral, gastrointestinal and genital flora, but may induce septic thrombophlebitis in the neighboring neck vessels when the infection is associated with an oropharyngeal abscess. The clinical spectrum may be wide, including abscess formation, bacteremia, puerperal infections, and septic shock\[[@j_jccm-2017-0029_ref_002], [@j_jccm-2017-0029_ref_003], [@j_jccm-2017-0029_ref_004], [@j_jccm-2017-0029_ref_005], [@j_jccm-2017-0029_ref_006]\]. Some reliable studies on *Fusobacterium*\[[@j_jccm-2017-0029_ref_007], [@j_jccm-2017-0029_ref_008]\] revealed an overall incidence of bacteremia of 0.55 cases per 100,000 population per year, and a wide spectrum of clinical features. Nohrström et al.\[[@j_jccm-2017-0029_ref_008]\] categorized the infections into 4 types: Lemierre's syndrome, sepsis in healthy patients, puerperal infections and sepsis in patients with underlying conditions, in an attempt to identify risk factors, comorbidities and predisposing conditions for favorable outcomes. They reported that some comorbid conditions, such as chronic kidney disease, dementia, cardiovascular disease, diabetes, and ICU admission, may be considered as risk factors for poor outcomes. Our aim was to characterize and analyze the clinical features and outcomes of patients with *Fusobacterium* infections, as well as predisposing diseases, and determine which variables were able to predict favorable or poor outcomes.

Methods {#j_jccm-2017-0029_s_002}
=======

Study design {#j_jccm-2017-0029_s_002_s_001}
------------

We conducted a retrospective cohort study at the Mostoles University Hospital in Madrid, a second-level general hospital serving a high variety of patients, and a teaching hospital for specializing postgraduates. The cohort was enrolled among patients cared for at the hospital between 2007 and 2016 (9.4 years), and they were evaluated retrospectively. All patients with an isolation of *Fusobacterium* species were identified in that timeframe through our Clinical Microbiology Laboratory, which is the only laboratory processing the clinical specimens in our area. We considered the patient to be suitable for entering the study if, along with the isolation of the fusobacteria, he/she exhibited clinical characteristics of an ongoing systemic infection. Thanks to our electronic record system, we were able to collect data regarding demographic features such as age and gender, clinical characteristics such as comorbidities, malignancy or immunocompromised status, hospital stay, medical or surgical management, and outcome. Sepsis was defined according to The Third International Consensus Definitions for Sepsis and Septic Shock\[[@j_jccm-2017-0029_ref_009]\]. Therefore, organ dysfunction was identified as an acute change in total SOFA (Sequential \[Sepsis-Related\] Organ Failure Assessment) score ≥2 points consequent to the infection caused by *Fusobacterium* species. Sepsis diagnosis was established if the patient met the organ dysfunction criteria and qSOFA (quick SOFA) score ≥2 of the following items: alteration in mental status, systolic blood pressure ≥100 mm Hg, or respiratory rate ≥22/min\[[@j_jccm-2017-0029_ref_010], [@j_jccm-2017-0029_ref_009]\].

Septic shock was defined by the presence of sepsis with persisting hypotension requiring vasopressors to maintain mean arterial pressure ≥65 mm Hg and having a serum lactate level \>2 mmol/L (18mg/dL) despite adequate fluid resuscitation. We defined severe infection as sepsis, need for ICU admission, bacteremia, peritonitis, disseminated intravascular coagulation, pelvic inflammatory disease, and septic shock. We were able to identify the source of infection thanks to the electronic records, imaging studies and microbiological isolations within the tissues.

Microbiological identification {#j_jccm-2017-0029_s_002_s_002}
------------------------------

Species-level identification was performed from positive cultures by manual methods, by means of the commercial system of multi-substrate analytical profile index, API 20A, that determines the phenotypical characteristics for anaerobic bacteria identification, both gram-negative and gram-positive. First isolations in our cohort were identified by automated methods---i. e. mass spectrometry Matrix-Assisted Laser Desorption Ionization Time Of Flight (MALDI-TOF MS)\[[@j_jccm-2017-0029_ref_011], [@j_jccm-2017-0029_ref_012]\].

Statistical analysis {#j_jccm-2017-0029_s_002_s_003}
--------------------

We performed a normality test for continuous variables using the Shapiro-Wilk test to assess the shape of the distribution of the continuous variables. Data are reported as the median, interquartile range (IQR) and percentage. We used either the Chi-square test or Fisher's exact test to assess the comparison between categorical variables, the Mann-Whitney-Wilcoxon test to establish comparisons between continuous and categorical variables, and Spearman's correlations to compare 2 continuous variables. Statistical analysis was performed using R version 3.3.2 (2016-10-31)\[[@j_jccm-2017-0029_ref_013]\]. For statistical comparison, a p-value of 0.05 was considered significant.

Results {#j_jccm-2017-0029_s_003}
=======

Demographic characteristics {#j_jccm-2017-0029_s_003_s_001}
---------------------------

We collected clinical records and microbiological data for 26 patients, of whom 9 were women (34.6%) and 17 were men (65.4%). The demographic features are summarized in [Table 1](#j_jccm-2017-0029_tab_001){ref-type="table"}. The median age was 46.5 years (IQR, 20.5 years). Four patients (15.4%) were active smokers. In terms of comorbidities, 4 patients (15.4%) had respiratory diseases (asthma or chronic obstructive pulmonary disease), and 4 patients (15.4%) had colorectal cancer, either prior to the *Fusobacterium* infection or diagnosed during the workup. Only 2 patients were considered to have immunocompromised status, due to either active HIV infection or chemotherapy treatment.

###### 

Demographic and clinical features, and outcomes of the studied population

  Characteristics                 Patients
  ------------------------------- -------------
  Total Patients                  26
  Age (years)                     46.5 (20.5)
  Gender (female)                 9 (34.6%)
  Gender (male)                   17 (65.4%)
  Asthma/COPD                     4 (15.4%)
  Smoking habit                   4 (15.4%)
  Colorectal cancer               4 (15.4%)
  Immunocompromised status        2 (7.7%)
  **Clinical features**           
  Sepsis                          9 (34.6%)
  **Sources of infection**        
  Peritonsillar abscess           6 (23.1%)
  Perforated acute appendicitis   3 (11.5%)
  Liver abscess                   2 (7.7%)
  Ovarian abscess                 2 (7.7%)
  Chorioamnionitis                2 (7.7%)
  Empyema                         3 (11.5%)
  Sigmoid colon abscess           3 (11.5%)
  Sinusitis                       2 (7.7%)
  Other complications             4 (15.4%)
  ICU admission                   7 (26.9%)
  Surgical treatment              18 (69.2%)

Date are given in number and percentages, except for age, which is given in median and interquartile range. COPD: chronic obstrutive pulmonary disease. Other complications: peritonitis, disseminated intravascular coagulation and pelvic inflammatory disease.

Presentation, sources of infection and outcome {#j_jccm-2017-0029_s_003_s_002}
----------------------------------------------

Clinical characteristics and outcomes are shown in [Table 1](#j_jccm-2017-0029_tab_001){ref-type="table"}. Sepsis was present in 9 patients (34.6%). Only 4 patients (15.4%) developed severe complications: peritonitis (2 patients), disseminated intravascular coagulation (1 patient), and pelvic inflammatory disease (1 patient). However, septic shock could not be identified in any patient. An intra-abdominal source of the infection was identified in 12 patients (46.1%), while an upper respiratory tract source was identified in 5 patients (19.2%), and a lower respiratory tract source in 2 patients (7.7%). None of the patients presented with Lemierre's syndrome. All 3 sigmoid colon abscesses were related to colorectal cancer, while 19 (73.1%) out of 26 patients were diagnosed with an abscess of any origin. Surgical management, whether open surgery, drainage or aspiration, was required in 18 patients (69.2%). While most of the patients stayed at the hospitalization ward, only 7 patients (26.9%) had to be admitted to the Intensive Care Unit (ICU). The median length of hospital stay was 11.5 days (IQR, 21 days). All 26 patients survived the *Fusobacterium* infection. Those who died months or years later could not be attributable to bacterial infections.

Microbiological features {#j_jccm-2017-0029_s_003_s_003}
------------------------

Sample specimens were obtained from exudate (57.7%), blood (30.8%) and tissue (11.5%). Data regarding microbiological characteristics are summarized in [Table 2](#j_jccm-2017-0029_tab_002){ref-type="table"}. *Fusobacterium necrophorum* and *F. nucleatum* were the most frequent isolations (92.3%). One case of *F. mortiferum* was identified, and only one *Fusobacterium* strain could not be identified. The annual incidence of fusobacterial infection was 1.78 per 100,000 population. Although the median age was very similar in both *F. nucleatum* (median 49.5 years, IQR 18.25) and *F. necrophorum* (median 40.5 years, IQR 35.25), the incidence follows a pattern in which *F. necrophorum* affects a younger population ([Figure 1](#j_jccm-2017-0029_fig_001){ref-type="fig"}).

![Boxplot showing age distribution by *Fusobacterium* species](jccm-03-141-g001){#j_jccm-2017-0029_fig_001}

###### 

Microbiological characteristics of the studied population

  Sample features               Sample size (percentage)
  ----------------------------- --------------------------
  Exudate sample (%)            15 (57.7%)
  Blood sample (%)              8 (30.8%)
  Tissue sample (%)             3 (11.5%)
  **Species isolated**          
  *Fusobacterium mortiferum*    1 (3.8%)
  *Fusobacterium necrophorum*   10 (38.5%)
  *Fusobacterium nucleatum*     14 (53.8%)
  *Fusobacterium sp*            1 (3.8%)
  Isolation in pure culture     21 (80.8%)

The isolation of bacteria in pure culture was more frequent (80.8%) than in the polymicrobial culture (19.2%). Strains of *Bacteroides fragilis, Escherichia coli, Klebsiella pneumoniae* and *Enterococcus faecium* were identified in the polymicrobial cultures.

Antimicrobial susceptibility testing {#j_jccm-2017-0029_s_003_s_004}
------------------------------------

Data regarding antimicrobial susceptibility were available in all 26 patients. All strains were susceptible to metronidazole, clindamycin, piperacillin/tazobactam and carbapenems. Resistance to penicillin was present in 16 isolates (9 cases of *F. nucleatum* and 7 cases of *F. necrophorum*).

Risk factors for severe disease {#j_jccm-2017-0029_s_003_s_005}
-------------------------------

The univariate analysis of the risk factors for severe infection is shown in [Table 3](#j_jccm-2017-0029_tab_003){ref-type="table"}. We found no significant differences in terms of gender, age, isolated species, presence of an abscess, immunosuppression status, presence of a tumor or respiratory disease between the patients presenting with severe infection and those with non-severe features. However, bacteremia (Chi-squared = 6.1553, df = 1, p-value = 0.0073) was statistically significant. When included in a linear regression analysis, bacteremia could be considered as an independent risk factor for severe infection (OR 0.611, 95% CI 0.240 - 0.981, p=0.002).

###### 

Univariate analysis of the risk factors for severe infection

  Variable              Severe infection (n=15)   Non-severe infection (n=11)   p-value
  --------------------- ------------------------- ----------------------------- ---------
  Gender (male)         10 (66.7%)                7 (46.69%)                    1
  Age (years)           49 +/- 22                 42 +/- 15.9                   0.420
  *F. nucleatum*        8 (53.36%)                6 (40.02%)                    1
  *F. necrophorum*      7 (46.69%)                3 (20.01%)                    0.551
  Bacteremia            8 (53.36%)                0                             0.007
  Abscess               10 (66.7%)                9 (60.93%)                    0.679
  Immunosuppression     3 (20.01%)                0                             0.238
  Cancer                3 (20.01%)                1 (6.67%)                     0.613
  Respiratory disease   1 (6.67%)                 3 (20.01%)                    0.374

Risk factors for length of hospital stay {#j_jccm-2017-0029_s_003_s_006}
----------------------------------------

After performing a univariate analysis of the risk factor for longer hospital stay, we could not find significant differences for length of hospital stay with regard to gender, age, *Fusobacterium* species, bacteremia, presence of an abscess, immunosuppression condition, malignant tumor, or respiratory disease.

Discussion {#j_jccm-2017-0029_s_004}
==========

The main findings in our case series showed the wide spectrum of clinical presentations caused by *Fusobacterium* infections, ranging from local pharyngeal or upper respiratory tract infections, such as sinusitis, to life-threatening infections that require ICU admission. Despite the severe infection, after appropriate management with antibiotic therapy or surgical procedures if required, patients were successfully discharged. *Fusobacterium* is an anaerobic pathogen usually involved in the development of Lemierre's syndrome\[[@j_jccm-2017-0029_ref_001]\], although other bacteria may also cause this complication of pharyngitis. Typical manifestations of Lemierre's syndrome include the development of a pyogenic thrombosis of the internal jugular vein, and septic emboli to the lungs, brain, and liver\[[@j_jccm-2017-0029_ref_002]\]. However, in our series we found no cases of Lemierre's syndrome, unlike some other case series which did identify the syndrome. Nevertheless, Lemierre's syndrome is an uncommon infection\[[@j_jccm-2017-0029_ref_002]\], with an annual incidence of between 0.05 and 0.09 per 100,000 population\[[@j_jccm-2017-0029_ref_002], [@j_jccm-2017-0029_ref_008]\], and like ours, there are other case series which did not find any cases presenting this syndrome\[[@j_jccm-2017-0029_ref_014]\].

*Fusobacterium* infections, whether soft-tissue or bacteremic infections, are uncommon. During the 10-year period of observation, we found 26 cases of fusobacterial infections in a population of 155,000 inhabitants. The annual incidence, according to our retrospective study, was 1.78 per 100,000 population, and the incidence of bacteremia was 0.53 per 100,000 population, which is very similar to other retrospective studies: Nohrström et al.\[[@j_jccm-2017-0029_ref_008]\] reported an annual incidence of bacteremia of 0.55 per 100,000 population, and the series by Afra et al.\[[@j_jccm-2017-0029_ref_007]\] also reported an incidence of 0.55 per 100,000 per year. Pett et al.\[[@j_jccm-2017-0029_ref_015]\] reported an incidence of 0.76 cases per 100,000 per year.

An interesting feature was the preference *F. necrophorum* showed for healthy, younger patients. *F. nucleatum* cases had a median age of 49.5 years (IQR 18.25), while *F. necrophorum* had a median of 40.5 years (IQR 35.25). Although the median only differs by 9 years, [Figure 1](#j_jccm-2017-0029_fig_001){ref-type="fig"} shows that *F. nucleatum* did not affect individuals under 40 years of age, while *F. necrophorum* affected individuals up to 18 years of age. Other studies are more consistent with these findings, such as that by Afra et al.\[[@j_jccm-2017-0029_ref_007]\], who reported an obvious pattern between *F. necrophorum* (median of 21 years) and *F. nucleatum* (median of 53.5 years), and Pett et al.\[[@j_jccm-2017-0029_ref_015]\], who reported that *F. necrophorum* affected patients under 47 years of age.

We also observed a male predominance (65.4%) versus female infections (34.6%). These findings were consistent with other publications\[[@j_jccm-2017-0029_ref_007], [@j_jccm-2017-0029_ref_015]\].

*F. necrophorum* and *F. nucleatum* were the most common isolated species in our study (24 out of 26 patients), consistent with other retrospective studies\[[@j_jccm-2017-0029_ref_002], [@j_jccm-2017-0029_ref_007], [@j_jccm-2017-0029_ref_015]\]. We only reported one strain of *F. mortiferum*, and one strain of unidentified *Fusobacterium*. Other studies, however, reported the isolation of *F. varium* and *F. gonidiaformans* \[[@j_jccm-2017-0029_ref_015]\].

In addition to the above-mentioned low likelihood of causing bacteremic infections, *Fusobacterium* species tend to involve abscess formation (17 patients out of our 26 reported cases), perhaps due to an attempt to protect an anaerobic environment from the oxidative conditions of the host. In our series, not all abscesses required surgical treatment: one patient presenting with a liver abscess was managed with antibiotic therapy only, with a good outcome at discharge. In our study, all abscesses were considered to arise from primary infections, except the 2 cases of liver abscesses, the primary source of which was probably the disruption of the mucosal colonic barriers related to colorectal cancer. However, some publications have reported liver abscessation related to periodontal disease \[[@j_jccm-2017-0029_ref_006]\] without Lemierre's syndrome, or after a dental procedure\[[@j_jccm-2017-0029_ref_016]\] (dental cleaning in an otherwise healthy patient). Colorectal tumors, diverticular disease and even a recent colonoscopy\[[@j_jccm-2017-0029_ref_017]\] may be the potential source of *Fusobacterium* infection. A recent publication reported a liver abscess in an immunocompetent patient with no recognizable risk factors for *Fusobacterium* infection\[[@j_jccm-2017-0029_ref_018]\].

The liver is the most common visceral organ in which abscesses can be found, but very few cases of *Fusobacterium* as a causative pathogen have been reported. With regard to Lemierre's syndrome, about 2-4% of cases develop liver abscesses when metastatic emboli occur\[[@j_jccm-2017-0029_ref_002]\]. Liver abscesses are often polymicrobial, due to a complication of peritonitis, spreading from a biliary infection or via hematogenous spread in the context of a systemic infection.\[[@j_jccm-2017-0029_ref_005]\] Other risk factors for a liver abscess include underlying gastrointestinal neoplasm, such as colorectal or hepatobiliary carcinoma, pancreatic abscesses, diabetes and a certain degree of immunosuppression\[[@j_jccm-2017-0029_ref_003]\]. Although the liver is the most common site of metastatic visceral abscesses, the presence of septic emboli involving this organ is uncommon. With no evidence of pharyngeal infection, it is less common to diagnose a liver abscess in an immunocompetent patient, and a workup should therefore be performed in order to identify the primary focus of the infection\[[@j_jccm-2017-0029_ref_005], [@j_jccm-2017-0029_ref_007]\].

In our series, malignancy, in the form of colorectal cancer, was found in 4 patients (15.4%), associated with *F. nucleatum* in 2 patients, and *F. necrophorum* in the other 2 cases. Three patients with this underlying condition showed features of severe infection, and the need for ICU admission. Only one patient presented with a solitary liver abscess, and the malignancy was diagnosed in the ensuing workup. Several studies have reported the association between malignancy and *Fusobacterium* infections\[[@j_jccm-2017-0029_ref_007], [@j_jccm-2017-0029_ref_008], [@j_jccm-2017-0029_ref_014], [@j_jccm-2017-0029_ref_019]\], although other comorbidities such as diabetes, dementia, respiratory disease, and heart disease may also be risk factors\[[@j_jccm-2017-0029_ref_007]\]. In our study, however, despite the fact that malignancy, chronic obstructive pulmonary disease, and immunosuppressed status were encoded in our electronic dataset, we could not find any statistical association between these risk factors and the likelihood of severe infection. The only identifiable risk factor for a severe infection (sepsis or ICU admission) was the presence of bacteremia.

Regarding the outcomes, we were able to report a low mortality due to *Fusobacterium* infections since we did not record any deaths attributable to this pathogen. These data are not consistent with those obtained by other publications, which report a mortality rate of 1%,\[[@j_jccm-2017-0029_ref_020]\] 11%,\[[@j_jccm-2017-0029_ref_007]\] or even 47.4%\[[@j_jccm-2017-0029_ref_021]\].

Our study has a number of limitations. Although patient data were available, given the uncommon nature of these infections, even in a 10-year observation period, the size of our cohort remained small (26 patients), in contrast with other aforementioned publications. For this reason, we believe our results regarding risk factors lack statistical significance. With further studies, researchers should be able to shed light on the mechanisms of infection, underlying conditions, and the risk factors involving *Fusobacterium* infections.

Conclusions {#j_jccm-2017-0029_s_005}
===========

*Fusobacterium* species are the causative pathogen of uncommon infections. The overall incidence found in our study is consistent with other publications. *F. necrophorum* tends to cause infection in younger individuals, while *F. nucleatum* has a preference for older patients. The clinical spectrum is wide, ranging from upper respiratory tract infections, such as sinusitis or pharyngitis, to abscess formation and septic shock. Until sample cultures can yield any definitive results, empirical treatment with broad-spectrum antibiotics, such as metronidazole or carbapenems, should be initiated. This treatment should be corrected according to sensitivities and drug resistances. The elective treatment for an abscess is usually percutaneous or surgical drainage, although in some cases, broad-spectrum, systemic antibiotics and medical management may be enough to achieve the complete resolution of the abscess.
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